Ophthalmic Drugs Global Market Report 2025

Ophthalmic Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ophthalmic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for ophthalmic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ophthalmic drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Type: Prescription Drugs; Over-The-Counter Drugs

2) By Class: Anti-Allergy; Anti-Inflammatory; Anti-Glaucoma; Other Classes

3) By Disease: Dry Eye; Eye Allergy; Glaucoma; Eye Infection; Retinal Disorders; Uveitis; Other Diseases

4) By Dosage Form: Liquid Ophthalmic Drug Forms; Solid Ophthalmic Drug Forms; Semisolid Ophthalmic Drug Forms; Multicompartment Drug Delivery Systems

5) By Distribution Channel: Hospital Pharmacies; Drug Stores; Online Pharmacies

Subsegments:

1) By Prescription Drugs: Antiglaucoma Agents; Anti-inflammatory Drugs; Antibiotics; Antivirals; Corticosteroids; Other Prescription Drugs

2) By Over-The-Counter Drugs: Artificial Tears; Allergy Relief Medications; Redness Relievers; Ocular Vitamins And Supplements; Other OTC Drugs

Companies Mentioned: AbbVie Inc.; Alcon Inc.; Bausch & Lomb Incorporated; F. Hoffmann-La Roche Ltd.; Novartis AG

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Ophthalmic Drugs Market Characteristics
3. Ophthalmic Drugs Market Trends And Strategies
4. Ophthalmic Drugs Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
5. Global Ophthalmic Drugs Growth Analysis And Strategic Analysis Framework
5.1. Global Ophthalmic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Ophthalmic Drugs Market Growth Rate Analysis
5.4. Global Ophthalmic Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Ophthalmic Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Ophthalmic Drugs Total Addressable Market (TAM)
6. Ophthalmic Drugs Market Segmentation
6.1. Global Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prescription Drugs
Over-The-Counter Drugs
6.2. Global Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anti-Allergy
Anti-Inflammatory
Anti-Glaucoma
Other Classes
6.3. Global Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dry Eye
Eye Allergy
Glaucoma
Eye Infection
Retinal Disorders
Uveitis
Other Diseases
6.4. Global Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Liquid Ophthalmic Drug Forms
Solid Ophthalmic Drug Forms
Semisolid Ophthalmic Drug Forms
Multicompartment Drug Delivery Systems
6.5. Global Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Drug Stores
Online Pharmacies
6.6. Global Ophthalmic Drugs Market, Sub-Segmentation Of Prescription Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antiglaucoma Agents
Anti-inflammatory Drugs
Antibiotics
Antivirals
Corticosteroids
Other Prescription Drugs
6.7. Global Ophthalmic Drugs Market, Sub-Segmentation Of Over-The-Counter Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Artificial Tears
Allergy Relief Medications
Redness Relievers
Ocular Vitamins And Supplements
Other OTC Drugs
7. Ophthalmic Drugs Market Regional And Country Analysis
7.1. Global Ophthalmic Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Ophthalmic Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Ophthalmic Drugs Market
8.1. Asia-Pacific Ophthalmic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Ophthalmic Drugs Market
9.1. China Ophthalmic Drugs Market Overview
9.2. China Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Ophthalmic Drugs Market
10.1. India Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Ophthalmic Drugs Market
11.1. Japan Ophthalmic Drugs Market Overview
11.2. Japan Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Ophthalmic Drugs Market
12.1. Australia Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Ophthalmic Drugs Market
13.1. Indonesia Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Ophthalmic Drugs Market
14.1. South Korea Ophthalmic Drugs Market Overview
14.2. South Korea Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Ophthalmic Drugs Market
15.1. Western Europe Ophthalmic Drugs Market Overview
15.2. Western Europe Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Ophthalmic Drugs Market
16.1. UK Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Ophthalmic Drugs Market
17.1. Germany Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Ophthalmic Drugs Market
18.1. France Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Ophthalmic Drugs Market
19.1. Italy Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Ophthalmic Drugs Market
20.1. Spain Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Ophthalmic Drugs Market
21.1. Eastern Europe Ophthalmic Drugs Market Overview
21.2. Eastern Europe Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Ophthalmic Drugs Market
22.1. Russia Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Ophthalmic Drugs Market
23.1. North America Ophthalmic Drugs Market Overview
23.2. North America Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Ophthalmic Drugs Market
24.1. USA Ophthalmic Drugs Market Overview
24.2. USA Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Ophthalmic Drugs Market
25.1. Canada Ophthalmic Drugs Market Overview
25.2. Canada Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Ophthalmic Drugs Market
26.1. South America Ophthalmic Drugs Market Overview
26.2. South America Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Ophthalmic Drugs Market
27.1. Brazil Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Ophthalmic Drugs Market
28.1. Middle East Ophthalmic Drugs Market Overview
28.2. Middle East Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Ophthalmic Drugs Market
29.1. Africa Ophthalmic Drugs Market Overview
29.2. Africa Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Ophthalmic Drugs Market Competitive Landscape And Company Profiles
30.1. Ophthalmic Drugs Market Competitive Landscape
30.2. Ophthalmic Drugs Market Company Profiles
30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Bausch & Lomb Incorporated Overview, Products and Services, Strategy and Financial Analysis
30.2.4. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
31. Ophthalmic Drugs Market Other Major And Innovative Companies
31.1. Pfizer Inc.
31.2. Regeneron Pharmaceuticals Inc.
31.3. Santen Pharmaceutical Co. Ltd.
31.4. Sun Pharmaceutical Industries Limited
31.5. Teva Pharmaceutical Industries Ltd.
31.6. Merck & Co. Inc.
31.7. Nicox S.A.
31.8. Coherus Biosciences Inc.
31.9. Johnson & Johnson
31.10. Otsuka Pharmaceutical Co. Ltd.
31.11. Viatris Inc.
31.12. Mitotech SA
31.13. Akorn Incorporated
31.14. GlaxoSmithKline plc
31.15. Bayer AG
32. Global Ophthalmic Drugs Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Ophthalmic Drugs Market
34. Recent Developments In The Ophthalmic Drugs Market
35. Ophthalmic Drugs Market High Potential Countries, Segments and Strategies
35.1 Ophthalmic Drugs Market In 2029 - Countries Offering Most New Opportunities
35.2 Ophthalmic Drugs Market In 2029 - Segments Offering Most New Opportunities
35.3 Ophthalmic Drugs Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings